ClinicalTrials.govpublic full text
Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial
recurrent/metastatic endometrial cancer, adebrelimab, apatinib, pd-l1, maintenance immune-targeted combination therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 836836
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.